Search All News
Columbia Psychiatry is among the principal investigators in biotech Compass Pathways study of more than 200 patients.
Ecstasy "needs to be looked at in a very careful and rigorously controlled way to accrue evidence showing what it can do and what its potential liability is," says Dr. Jeffrey Lieberman.
Source:New ScientistJanuary 18, 2017
While some people may benefit from sharing their experiences, others risk experiencing more trauma by recalling them, says Dr. Elias Dakwar, Columbia University’s Division on Substance Abuse.